Experimental mRNA Vaccine Shows Promise Against Multiple Ebola Viruses
Researchers at the Wuhan Institute of Virology have developed an experimental mRNA vaccine that may offer protection against multiple strains of the Ebola virus, including the Bundibugyo, Zaire, and Sudan viruses. The vaccine, tested on rodents, combines mRNA encoding the glycoproteins of each virus and a shared nucleoprotein within a lipid nanoparticle. This formulation aims to provide broad-spectrum protection by targeting the essential compounds for infection. The study, published in the Proceedings of the National Academy of Sciences, indicates that the vaccine conferred complete protection against the Zaire and Sudan viruses and strong protection against the Bundibugyo virus in mice. However, researchers caution that further testing in higher-order animals, such as primates, is necessary before human trials can commence. 
